BlackRock Institutional Trust Company, N.A. - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$15,355,000
+11.7%
2,620,238
+1.2%
0.00%0.0%
Q3 2016$13,746,000
-13.9%
2,588,613
+7.3%
0.00%
-33.3%
Q2 2016$15,974,000
+30.2%
2,413,012
-8.2%
0.00%
+50.0%
Q1 2016$12,270,000
-7.4%
2,627,474
+0.2%
0.00%0.0%
Q4 2015$13,248,000
+47.7%
2,623,417
+3.0%
0.00%0.0%
Q3 2015$8,967,000
-63.9%
2,547,411
+2.4%
0.00%
-50.0%
Q2 2015$24,818,000
-25.4%
2,486,812
-4.8%
0.00%
-20.0%
Q1 2015$33,256,000
-2.9%
2,612,394
+8.0%
0.01%0.0%
Q4 2014$34,234,000
-2.0%
2,419,339
-4.8%
0.01%
-16.7%
Q3 2014$34,938,000
-11.1%
2,540,927
-0.5%
0.01%
-14.3%
Q2 2014$39,281,000
-10.0%
2,554,011
-0.3%
0.01%
-12.5%
Q1 2014$43,630,000
+40.8%
2,560,460
+7.0%
0.01%
+60.0%
Q4 2013$30,996,000
+26.2%
2,393,507
-1.7%
0.01%0.0%
Q3 2013$24,564,000
+44.0%
2,434,465
+6.6%
0.01%
+66.7%
Q2 2013$17,061,0002,283,8930.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$22,357,00015.70%
VHCP Management, LLC 1,000,273$17,045,0008.86%
HARVEY CAPITAL MANAGEMENT INC 915,800$15,605,0006.22%
Baupost Group 6,310,850$107,537,0002.60%
SECTORAL ASSET MANAGEMENT INC 3,537,590$60,281,0002.48%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 587,504$10,011,0002.31%
Knoll Capital Management, LLC 200,000$3,408,0001.76%
Camber Capital Management LP 1,250,000$21,300,0001.67%
NORTHPOINTE CAPITAL LLC 877,875$14,958,0001.52%
DAFNA Capital Management LLC 100,000$1,704,0001.46%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders